References
- Girelli D, Busti F, Brissot P, et al. Hemochromatosis classification:
update and recommendations by the BIOIRON Society. Blood .
2022;139:3018.
- Walton C, Kelly WF, Laing I, Bu’lock DE. Endocrine abnormalities in
idiopathic haemochromatosis. QJ Med. 1983;52:99.
- Brown S, Torrens LA. Ironing out the rough spots—cognitive
impairment in haemochromatosis. BMJ Case Rep. 2012;2012.
- Smith LH Jr. Overview of hemochromatosis. West J Med. 1990;
153:296.
- Niederau C, Fischer R, Sonnenberg A, et al. Survival and causes of
death in cirrhotic and in noncirrhotic patients with primary
hemochromatosis. N Eng J Med. 1985;313:1256.
- Carniel E, Mazigh D, Mollaret HH. Expression of iron-regulated
proteins in Yersinia species and their relation to virulence.Infect Immun. 1987;55:277.
- McNally A, Thomson NR, Reuter S, Wren BW. ‘Add, stir and reduce’:
Yersinia spp.as model bacteria for pathogen evolution. Nat Rev
Microbiol. 2016;14:177.
- Centers for Disease Control and Prevention (CDC). Red blood cell
transfusions contaminated with Yersinia enterocolitica—United
States, 1991-1996, and initiation of a national study to detect
bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep
1997;46:553.
- Bottone EJ. Yersinia enterocolitica: Revisitation of an Enduring Human
Pathogen. Clin Microbiol Newsletter. 2015;37:1.
- Van der Heijden IM, Res PC, Wilbrink B, et al. Yersinia
enterocolitica: a cause of chronic polyarthritis. Clin Infect
Dis. 1997;25:831.
- Lee LA, Gerber AR, Lonsway DR, et al. Yersinia enterocolitica O:3
infections in infants and children, associated with the household
preparation of chitterlings. N Engl J Med. 1990;322:984.
- El Qouqa IA, El Jarou MA, Samaha AS, et al. Yersinia enterocolitica
infection among children aged less than 12 years: a case-control
study. Int J Infect Dis. 2011;15:e48.
- Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of
Yersinia enterocolitica septicemia: a retrospective review of 43
cases. Clin Infect Dis. 1993;17:405.
- Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med. 1989;321:16.
- Leirisalo-Repo M. Yersinia arthritis. Acute clinical picture and
long-term prognosis. Contrib Microbiol Immunol. 1987;9:145.
- Tsubokura M. Yersinioses other than plague. In: Laboratory Diagnosis
of Infectious Diseases, Balows A, Hausler WJ Jr, Ohashi M, Turano A
(Eds). Springer-Verlag, New York City. 1989. p.540.
- Head CB, Whitty DA, Ratnam S. Comparative study of selective media for
recovery of Yersinia enterocolitica. J Clin Microbiol. 1982;16:615.
- Pai CH, Gillis F, Tuomanen E, Marks MI. Placebo-controlled
double-blind evaluation of trimethoprim-sulfamethoxazole treatment of
Yersinia enterocolitica gastroenteritis. J Pediatr. 1984;104:308.
- Ostroff SM, Kapperud G, Lassen J, et al. Clinical features of sporadic
Yersinia enterocolitica infections in Norway. J Infect Dis. 1992;166:812.
- Jackson MA, Schutze GE. COMMITTEE ON INFECTIOUS DISEASES. The Use of
Systemic and Topical Fluoroquinolones. Pediatrics. 2016;138.